Vision & Mission
Our Vision
Evidence-based decision making on vaccines
Our Mission
Delivering timely and robust real-world evidence on vaccines and cutting-edge methodology through a European community of expert organisations
Who we are
A not-for-profit international association based in Europe
ExploreA growing community of 28 members including research centres and public health institutions
ExploreA collective of experts in epidemiology, vaccinology, statistics, data science, medicine, project management, communication and related fields
ExploreWhat we do
Our key activities and focus areas
Collaborative studies
We conduct collaborative post-licensure studies on vaccine benefits, risk, and coverage utilising primary and secondary health data.
Harmonised workflows
We harmonise workflows through a quality management system, a common framework and shared tools including the ConcePTION Common Data Model.
Co-creation
We co-create through working groups and taskforces, and share knowledge and resources, building synergy across stakeholders.
Innovation
We actively invest in innovation and development in the rapid generation of RWE on vaccines including the creation of tools and methodologies.
Knowledge sharing
We stimulate scientific discussion and debate among members and the wider scientific community, by organising webinars, journal clubs and meetings.
Explore all activities
View allLatest updates
Stay up to date with our activities and publications
New edition of VAC4EU Community Newsletter
We've certainly been busy since our last newsletter in January, with a lot to share in this new edition of the VAC4EU Community Newsletter. What has the network been up to so far in 2025, anyway? Find out in the newest edition of the VAC4EU Community Newsletter. This edition covers network updates, recaps on recent events, upcoming conferences, results from COVID vaccine monitoring studies, and more!
Celebrate 5 years of VAC4EU with a symposium dedicated to pandemic preparedness
VAC4EU will be celebrating its 5th anniversary in Brussels on the 4th of November with a full-day hybrid symposium focused on discussing the role of vaccines in pandemic preparedness. Join experts from the fields of vaccinology, vaccine development, pharmacovigilance, pharmacoepidemiology, health policy, public health and regulatory practice to continue the discussion. Be sure to register!
Interested in vaccine safety in pregnancy? Join us for the next VAC4EU Journal Club appointment!
When public health becomes a political battlefield, pregnant women and their babies become collateral damage. In a world where vaccine misinformation outpaces science we urgently need transparent and robust evidence to protect vulnerable populations. Samantha Duckworth will present the paper “A Post-Authorisation Safety Study of a Respiratory Syncytial Virus Vaccine in Pregnant Women and Their Offspring in a Real-World Setting: Generic Protocol for a Target Trial Emulation.”
